We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$17.1M
Cap. Flow
+$8.08M
Cap. Flow %
4.69%
Top 10 Hldgs %
40.03%
Holding
148
New
11
Increased
106
Reduced
15
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 18.28%
2 Technology 15.4%
3 Healthcare 3.66%
4 Communication Services 3.58%
5 Consumer Discretionary 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWB icon
26
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.66B
$1.72M 1%
23,586
+973
+4% +$69.7K
VDE icon
27
Vanguard Energy ETF
VDE
$9.95B
$1.52M 0.88%
11,554
+2,858
+33% +$343K
WELL icon
28
Welltower
WELL
$169B
$1.52M 0.88%
16,236
+129
+0.8% +$11.7K
JNJ icon
29
Johnson & Johnson
JNJ
$618B
$1.47M 0.85%
9,258
+59
+0.6% +$9.39K
GS icon
30
Goldman Sachs
GS
$300B
$1.34M 0.78%
3,213
+123
+4% +$47.7K
SPY icon
31
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$1.26M 0.73%
2,414
+218
+10% +$109K
PAVE icon
32
Global X US Infrastructure Development ETF
PAVE
$14.9B
$1.23M 0.71%
30,850
+3,650
+13% +$132K
CIBR icon
33
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.7B
$1.22M 0.71%
21,559
+963
+5% +$54.1K
VYM icon
34
Vanguard High Dividend Yield ETF
VYM
$81.4B
$1.21M 0.7%
9,956
+695
+8% +$79.6K
VB icon
35
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$1.16M 0.67%
5,068
+218
+4% +$46.9K
IGHG icon
36
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
$1.15M 0.67%
14,981
+838
+6% +$63.8K
KO icon
37
Coca-Cola
KO
$377B
$1.13M 0.66%
18,543
+173
+0.9% +$10.4K
VIG icon
38
Vanguard Dividend Appreciation ETF
VIG
$112B
$1M 0.58%
5,483
+18
+0.3% +$3.16K
DVY icon
39
iShares Select Dividend ETF
DVY
$23.6B
$968K 0.56%
7,861
+453
+6% +$53K
SCHW
40
Charles Schwab
SCHW
$183B
$958K 0.56%
13,243
+1,018
+8% +$67K
ADI icon
41
Analog Devices
ADI
$179B
$941K 0.55%
4,758
+1,228
+35% +$236K
IBB icon
42
iShares Biotechnology ETF
IBB
$9.18B
$909K 0.53%
6,625
-142
-2% -$19.4K
PG icon
43
Procter & Gamble
PG
$336B
$883K 0.51%
5,442
+128
+2% +$20.1K
XLRE icon
44
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.63B
$874K 0.51%
22,118
+7,089
+47% +$276K
GSK icon
45
GSK
GSK
$104B
$864K 0.5%
20,146
-2,894
-13% -$119K
MRK icon
46
Merck
MRK
$322B
$847K 0.49%
6,419
+11
+0.2% +$1.36K
XLV icon
47
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$844K 0.49%
5,714
+595
+12% +$85.4K
LLY icon
48
Eli Lilly
LLY
$1.02T
$843K 0.49%
1,083
+256
+31% +$182K
XLP icon
49
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$823K 0.48%
10,771
-1,074
-9% -$79.4K
VOE icon
50
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
$818K 0.47%
5,244
+2,010
+62% +$295K

Similar funds

O'Rourke & Company's Q1 2024 Portfolio in Review

As of Q1 2024, O'Rourke & Company held 148 positions worth $172M, up 11% from $155M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

O'Rourke & Company deployed $8.08M of net new capital in Q1 2024, opening 11 new positions and adding to 106 existing holdings. Its largest new stake was Lazard: 8,171 shares worth $342K.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Blackrock, an estimated $234K trimmed.

  • O'Rourke & Company's largest Q1 2024 buy was Lazard: 8,171 shares worth $342K.
  • O'Rourke & Company added most to JPMorgan Equity Premium Income ETF in Q1 2024, an estimated $536K increase.
  • O'Rourke & Company's biggest Q1 2024 reduction was Blackrock, cutting an estimated $234K.
  • O'Rourke & Company fully exited iShares TIPS Bond ETF in Q1 2024, selling an estimated $1.16M.
  • O'Rourke & Company's ten largest holdings make up 40% of its $172M portfolio in Q1 2024.
  • O'Rourke & Company opened 11 new positions and closed 6 in Q1 2024.
  • O'Rourke & Company's portfolio value rose 11% quarter-over-quarter to $172M.

Based on O'Rourke & Company's 13F filing for Q1 2024, filed 18 Apr 2024.